Medicines Control Council approves TarcevaŽ in South Africa for treatment of non-small cell lung cancer

  • Editorial Office

Abstract

Thousands of South African lung cancer patients could now live longer and with improved quality of life if they receive Tarceva

(erlonitib), a novel alternative to traditional chemotherapy, recently approved by the Medicines Control Council (MCC).

Section
Press Releases